Evoke Wealth’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-5,873
Closed -$470K 206
2026
Q1
$470K Sell
5,873
-118
-2% -$9.73K 0.01% 421
2025
Q4
$511K Buy
5,991
+1,531
+34% +$126K 0.01% 386
2025
Q3
$347K Buy
4,460
+1,747
+64% +$136K 0.01% 474
2025
Q2
$212K Buy
+2,713
New +$202K ﹤0.01% 552
2022
Q4
Sell
-138
Closed -$11K 634
2022
Q3
$11K Sell
138
-11
-7% -$1.06K ﹤0.01% 736
2022
Q2
$14K Sell
149
-70
-32% -$7.25K ﹤0.01% 717
2022
Q1
$26K Buy
219
+7
+3% +$785 ﹤0.01% 612
2021
Q4
$27K Sell
212
-1
-0.5% -$117 ﹤0.01% 626
2021
Q3
$24K Sell
213
-24
-10% -$2.74K ﹤0.01% 610
2021
Q2
$25K Sell
237
-51
-18% -$4.81K ﹤0.01% 615
2021
Q1
$24K Buy
288
+150
+109% +$12.7K ﹤0.01% 558
2020
Q4
$13K Hold
138
﹤0.01% 541
2020
Q3
$11K Hold
138
﹤0.01% 544
2020
Q2
$10K Sell
138
-15
-10% -$1.07K ﹤0.01% 547
2020
Q1
$9.62K Sell
153
-111
-42% -$8.01K ﹤0.01% 509
2019
Q4
$20.5K Sell
264
-12
-4% -$937 ﹤0.01% 583
2019
Q3
$20.2K Buy
+276
New +$19.4K ﹤0.01% 658

Other funds holding EW

Evoke Wealth's EW Position: Q2 2026 in Review

Evoke Wealth sold out of Edwards Lifesciences (EW) in Q2 2026, closing a stake of 5,873 shares — an estimated $470K sold.

Evoke Wealth first reported a position in EW in Q3 2019 and held it in 17 quarters. The position peaked at $511K in Q4 2025. 1,325 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Evoke Wealth reported no remaining Edwards Lifesciences position as of Q2 2026 after selling out during the quarter.
  • Evoke Wealth sold 5,873 Edwards Lifesciences shares in Q2 2026, an estimated $470K.
  • Evoke Wealth first reported a position in Edwards Lifesciences in Q3 2019 and held it in 17 quarters.
  • Evoke Wealth's Edwards Lifesciences position peaked at $511K in Q4 2025.
  • 1,325 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Evoke Wealth's 13F filing for Q2 2026, filed 10 Aug 2026.